Australia on Thursday appointed Deutsche Bank, Goldman Sachs and Macquarie Capital as joint lead managers for the initial public offering of state-owned health insurer Medibank Private, tipped by local media to fetch about A$4 billion ($3.75 billion).

The sale of Medibank Private is part of an aggressive strategy by Australia's federal and state governments to sell off state-owned assets to pay down debt and fund investment in roads and other infrastructure projects.

"The precise timing and structure of the Medibank Private initial public offering is yet to be determined," Finance Minister Mathias Cormann said in a statement.

Medibank would rank among the biggest Australian floats of the year, alongside another health-related company, hospital operator Healthscope, which owners TPG Capital and The Carlyle Group are contemplating floating for an estimated A$5 billion.

 

Related Articles

Skadden, AMT, MHM, Davis Polk advise on Trial Holding’s $258 mln Japan IPO

by Nimitt Dixit |

Skadden, Arps, Slate, Meagher & Flom and Anderson Mori & Tomotsune have advised Japanese discount-store chain operator Trial Holdings on its $258 million initial public offering on the Tokyo Stock Exchange (TSE), the largest IPO of the year so far.

Cleary, Freshies lead on China shoemaker’s planned $1 bln HK IPO

by Rowena Muñiz |

Cleary Gottlieb Steen & Hamilton and JunHe are advising Chinese footwear and apparel maker Belle Fashion Group on its planned Hong Kong IPO that is set to raise between $500 million and $1 billion. Freshfields Bruckhaus Deringer and Haiwen & Partners are representing the joint sponsors.

INDIA REPORT: Capital Times on D-Street

by Nimitt Dixit |

It’s been a record-setting year for India’s IPO market, and law firms have reaped the benefits, representing issuing companies and lead managers. And the party isn’t expected to end any time soon: Lawyers believe there is a lot more is to come in 2024 despite the upcoming general elections.